BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 25694464)

  • 21. Muscle and statins: from toxicity to the nocebo effect.
    Pedro-Botet J; Climent E; Benaiges D
    Expert Opin Drug Saf; 2019 Jul; 18(7):573-579. PubMed ID: 31070941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin-Associated Myalgias and Muscle Injury-Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein.
    Mammen AL
    Rheum Dis Clin North Am; 2022 May; 48(2):445-454. PubMed ID: 35400370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of mitochondria in statin-induced myopathy.
    Apostolopoulou M; Corsini A; Roden M
    Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
    Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
    Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study.
    Casula M; Gazzotti M; Bonaiti F; OImastroni E; Arca M; Averna M; Zambon A; Catapano AL;
    J Intern Med; 2021 Jul; 290(1):116-128. PubMed ID: 33259671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Statin intolerance and statin-associated muscular pain].
    Stürzebecher PE; Schumann F; Kassner U; Laufs U
    Herz; 2022 Jun; 47(3):204-211. PubMed ID: 35451596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical markers of muscle damage and high serum concentration of creatine kinase in patients on statin therapy.
    Nogueira AA; Strunz CM; Takada JY; Mansur AP
    Biomark Med; 2019 Jun; 13(8):619-626. PubMed ID: 31157560
    [No Abstract]   [Full Text] [Related]  

  • 28. Statins, myalgia, and rhabdomyolysis.
    Tournadre A
    Joint Bone Spine; 2020 Jan; 87(1):37-42. PubMed ID: 30735805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.
    Chatzizisis YS; Koskinas KC; Misirli G; Vaklavas C; Hatzitolios A; Giannoglou GD
    Drug Saf; 2010 Mar; 33(3):171-87. PubMed ID: 20158283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin-associated muscle symptoms-Managing the highly intolerant.
    Backes JM; Ruisinger JF; Gibson CA; Moriarty PM
    J Clin Lipidol; 2017; 11(1):24-33. PubMed ID: 28391891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing the underestimated risk of statin-associated myopathy.
    Rallidis LS; Fountoulaki K; Anastasiou-Nana M
    Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Statin myopathy--rarity or reality?].
    Pella D
    Vnitr Lek; 2010 Sep; 56(9 Suppl):972-6. PubMed ID: 21137170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing statin myopathy.
    Venero CV; Thompson PD
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):121-36. PubMed ID: 19217515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narrative review: statin-related myopathy.
    Joy TR; Hegele RA
    Ann Intern Med; 2009 Jun; 150(12):858-68. PubMed ID: 19528564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expert opinion: the therapeutic challenges faced by statin intolerance.
    Patel J; Martin SS; Banach M
    Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel strategies for managing dyslipidemia: treatment beyond statins.
    Ling H; Burns TL; Hilleman DE
    Postgrad Med; 2012 Nov; 124(6):43-54. PubMed ID: 23322138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Statin intolerance].
    Tonstad S
    Tidsskr Nor Laegeforen; 2017 Jan; 137(1):36-38. PubMed ID: 28073228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin-induced myopathies.
    Tomaszewski M; Stępień KM; Tomaszewska J; Czuczwar SJ
    Pharmacol Rep; 2011; 63(4):859-66. PubMed ID: 22001973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A practical algorithm for the management of patients with statin-associated muscle symptoms.
    Rallidis LS
    Hellenic J Cardiol; 2020; 61(2):137-140. PubMed ID: 31756491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin-associated myopathy.
    Thompson PD; Clarkson P; Karas RH
    JAMA; 2003 Apr; 289(13):1681-90. PubMed ID: 12672737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.